Di Chen

机构：Chinese Academy of Tropical Agricultural Sciences, Ministry of Education of the People's Republic of China, China Pharmaceutical University, Second Military Medical University, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Changhai Hospital, Hubei Provincial Women and Children's Hospital, Wuhan Children's Hospital, First Affiliated Hospital of Zhengzhou University, Huazhong University of Science and Technology, China Medical University · ORCID：0000-0002-2181-4703

发表论文 129 篇 · 总被引 6274 次 · h-index 41

代表论文

• Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform (2024 · iMeta · 被引 135)
• Writers, readers, and erasers RNA modifications and drug resistance in cancer (2024 · Molecular Cancer · 被引 106)
• Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks (2024 · Nature Communications · 被引 49)
• Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma (2023 · Cancer Cell International · 被引 27)
• Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy (2024 · Clinical and Translational Medicine · 被引 19)
• Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma (2024 · Cancer Cell International · 被引 16)